In the FY2021/12 3Q (cumulative period), sales resulted in 23 billion yen, EBITDA reached 5.1 billion yen, and net income was 2.9 billion yen. Sales increased by +38.2% year-on-year due to growth in existing business and contribution from vaccination-related spot business, and EBITDA by +43.3% year-on-year, which grew at a faster pace than the increase in costs associated with the strategic office space expansion and growth in personnel numbers.

上場市場

東証一部

銘柄コード

7354

業種

Service industry

事業内容

Consulting business、Temporary staffing business、Marketing business、BPO

RELATED MOVIES